The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors

The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors

Suheyla Ekemen,1,2 Ebru Bilir,3 Hagar Elsayed Akram Soultan,3 Sadia Zafar,3 Figen Demir,4 Babek Tabandeh,5 Sadik Toprak,6 Ozlem Yapicier,7 Cevayir Coban2,8,9 1Vocational School of Health Services, Acibadem University, Istanbul, Turkey; 2Division of Malaria Immunology, Department of Microbiology and...

Full description

Bibliographic Details
Main Authors: Ekemen S, Bilir E, Soultan HEA, Zafar S, Demir F, Tabandeh B, Toprak S, Yapicier O, Coban C
Format: Article
Language:English
Published: Dove Medical Press 2024-01-01
Series:Breast Cancer: Targets and Therapy
Subjects:
breast cancer
programmed cell death ligand-1 (pd-l1)
lipocalin 2 (lcn2)
immunotherapy
triple-negative breast cancer (tnbc)
Online Access:https://www.dovepress.com/the-programmed-cell-death-ligand-1-and-lipocalin-2-expressions-in-prim-peer-reviewed-fulltext-article-BCTT

Internet

https://www.dovepress.com/the-programmed-cell-death-ligand-1-and-lipocalin-2-expressions-in-prim-peer-reviewed-fulltext-article-BCTT

Similar Items